2013NeurologyRequires access

Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders (S60.004)

John S. Tzartos, Christos L. Stergiou, Konstantinos Kilidireas, Paraskevi Zisimopoulou, Thomas V. Thomaidis, Socrates J. Tzartos

Open publisher page 0 citations

Abstract

OBJECTIVE: To investigate whether patients with neuromyelitis optica (NMO) spectrum disorders (NMOsd) seronegative for autoantibodies to aquaporin-4 (AQP4), a water-channel expressed in human CNS astrocytes, have autoantibodies to aquaporin-1(AQP1).

About this research paper

What this paper is about

OBJECTIVE: To investigate whether patients with neuromyelitis optica (NMO) spectrum disorders (NMOsd) seronegative for autoantibodies to aquaporin-4 (AQP4), a water-channel expressed in human CNS astrocytes, have autoantibodies to aquaporin-1(AQP1).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To investigate whether patients with neuromyelitis optica (NMO) spectrum disorders (NMOsd) seronegative for autoantibodies to aquaporin-4 (AQP4), a water-channel expressed in human CNS astrocytes, have autoantibodies to aquaporin-1(AQP1).

Key concepts: Neuromyelitis optica, Aquaporin 4, Autoantibody, Medicine, Spectrum disorder, Immunology, Internal medicine, Antibody

Related papers

Back to paper searchBrowse research topicsOriginal source
Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders (S60.004) — Research Paper | ScholarLens